Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-02-17

Clinical Trial Update: Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes

View source ↗

Summary

This clinical trial update describes a planned study in Chinese patients with Type 1 diabetes to assess glucose-lowering drugs as an adjunct to insulin therapy.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Type 1 Diabetes Mellitus | Status: NOT_YET_RECRUITING